Clinical Trials in Phoenix

Showing 13761-13780 of 14,291 trials

COMPLETEDPhase 1< 1 mile

Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors

NCT00492830

This study is being performed to evaluate the safety and tolerability of the TRC093 antibody.

CancerNeoplasm Metastasis

Tracon Pharmaceuticals Inc.19 participantsStarted Jun 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Santa Monica, California, United States

COMPLETEDPhase 3< 1 mile

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393

Patients with HIV who are virologically suppressed on a lopinavir/ritonavir combination highly active antiretroviral therapy (HAART) regimen but with elevated non-HDL cholesterol are randomized to remain on lopinavir/ritonavir or change to atazanavir/ritonavir in combination with current nucleoside reverse transcriptase inhibitors (NRTIs).

HIV Infections

Bristol-Myers Squibb192 participantsStarted Jan 2004

Phoenix, Arizona, United States • Bakersfield, California, United States • Los Angeles, California, United States +11 more locations

Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

Find Trials by Condition in Phoenix

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Safety and Tolerability Study of the Taris Placebo System

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Safety and Efficacy Evaluation of Erbium Treatment

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Quality of Life in Pediatric Inflammatory Bowel Disease

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

North American Study for the Treatment of Refractory Ascites (NASTRA)